{"id":66540,"date":"2025-04-10T12:01:46","date_gmt":"2025-04-10T12:01:46","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/04\/10\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/"},"modified":"2025-04-10T12:01:46","modified_gmt":"2025-04-10T12:01:46","slug":"avalyn-to-participate-in-upcoming-investor-conference-in-april","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/","title":{"rendered":"Avalyn to Participate in Upcoming Investor Conference in April"},"content":{"rendered":"<div>\n<p align=\"left\">CAMBRIDGE, Mass., April  10, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HKjUbgjzfZgiadHYzTDESU7HB1NJ2GQ5U6dyQ1uor7WN0HwOsDSRLBbZ611kYFN9ihhct384XtIEaXHCXqoLdOJrIPFLUkU33IPYztJRbq8=\" rel=\"nofollow\" target=\"_blank\" title=\"Avalyn Pharma Inc.\">Avalyn Pharma Inc.<\/a>, a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the Citi Biotech Private Access Day.<\/p>\n<table style=\"border-collapse: collapse; border-collapse:collapse ;\">\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: top ; \"><strong>Format:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0 \u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">1&#215;1 Meetings<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: top ; \"><strong>Date:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">Thursday, April 24, 2025<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: top ; \"><strong>Location:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">Virtual<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;   text-align: left;   padding-left: 30.0px; vertical-align: top ; \"><strong>Participants:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">Lyn Baranowski, CEO; Douglas Carlson, CFO &amp; CBO<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p><strong>About Avalyn Pharma<\/strong><br \/>Avalyn is reimagining the future of pulmonary fibrosis treatment with a pipeline of new inhaled formulations of approved medicines designed to reduce systemic exposure and deliver medication directly to the site of disease. Pulmonary fibrosis is characterized by scarring of lung tissue, decline in lung function, and reduced exercise capacity and quality of life, and is associated with increased mortality. Currently approved therapeutic options slow pulmonary fibrosis progression but are associated with significant toxicities that restrict their use and dosing. Avalyn\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cm7ElwmoOEa0WF3JaR4u58KdQe1h-y0mYx4l4--tFpIgPU20-4Pu86-BJk8e_0OvnQAfJQAVTmTezKRf8LkSBj31o1psd25ZFYs1IM1eEmtXMhYyAwCnAcjFT7qBN8sK\" rel=\"nofollow\" target=\"_blank\" title=\"inhaled approach\">inhaled approach<\/a> tackles the underlying pathophysiology of pulmonary fibrosis at its source and is designed to reduce systemic exposure and deliver medication directly to the site of disease. Avalyn\u2019s lead program, AP01, is an optimized inhaled formulation of pirfenidone, currently being studied in the ongoing MIST Phase 2b study in progressive pulmonary fibrosis (PPF). AP01 has been assessed in over 150 individuals with different forms of pulmonary fibrosis and demonstrated clinical proof-of-concept with improved efficacy and safety compared to historical data with existing therapies. The company completed two Phase 1 studies for its second program, AP02, inhaled nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=di1RDO7QmuFEiGyg1fikr_jeDrFpMqPUIsRQfn5uNwsYYg94qM_yR3ow8By_ExVZLEqEiGX-3Wqh7lhYNL-OHoo_nEYfpQCS3hmaTbYpkIs=\" rel=\"nofollow\" target=\"_blank\" title=\"avalynpharma.com\">avalynpharma.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R96F35gwYQGHAyfMCs3fOnKxq-qdWZteJPZUCcTOfoMHcGC12NAoMqFfkHzZjLBRf5EayVv4ob2QCQdmco2XqhfA4KzAfb7qU44f7mSAVMJs3Vm-IED5ZYwDja51rpwQ\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Alex Straus, THRUST<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-IO0jYoaxCr0MlCnqX5g4RE78MUI6WUI3nq1AVe8oMj3ddjMEdiEpXSlbk_9HAp3o6yv1LDCQ9ncwUB36Zhwa0ecDUCIlOj-FORZ1veN91s=\" rel=\"nofollow\" target=\"_blank\" title=\"alex@thrustsc.com\">alex@thrustsc.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qlXHcjINiNamagpdUQXiikxmBgldslkWs9iTAscPfS36RzvHEhRt1wNhNlkqKRSv8_8nNgx0soM5zwRfSspS6WZ00KiNdIEljQNg4isui5U=\" rel=\"nofollow\" target=\"_blank\" title=\"ir@avalynpharma.com\">ir@avalynpharma.com<\/a><\/p>\n<p><strong>Media Contact:<\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WDEMvU0quWrHfj8sDBZpynxB3W_50YCrnPLB9T0MttMGrPyoega9iaMkrQfiulInXExRwEor1t1-4_5uZ3ppNl9JmiUGjG5rn1vzMB2o5Qc=\" rel=\"nofollow\" target=\"_blank\" title=\"media@avalynpharma.com\">media@avalynpharma.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZmFjNDYwY2EtNTRiZi00ZmQyLTllOGMtMDhmY2M0ODdjMzgzLTEyNjY2NzQtMjAyNS0wNC0xMC1lbg==\/tiny\/Avalyn-Pharma-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the Citi Biotech Private Access Day. Format: \u00a0 \u00a0 1&#215;1 Meetings Date: \u00a0 Thursday, April 24, 2025 Location: \u00a0 Virtual [&#8230;]\n","protected":false},"author":1,"featured_media":66541,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-66540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Avalyn to Participate in Upcoming Investor Conference in April - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avalyn to Participate in Upcoming Investor Conference in April\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inh\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-10T12:01:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Avalyn-Pharma-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Avalyn to Participate in Upcoming Investor Conference in April\",\"datePublished\":\"2025-04-10T12:01:46+00:00\",\"dateModified\":\"2025-04-10T12:01:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\"},\"wordCount\":283,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\",\"name\":\"Avalyn to Participate in Upcoming Investor Conference in April - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-04-10T12:01:46+00:00\",\"dateModified\":\"2025-04-10T12:01:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avalyn to Participate in Upcoming Investor Conference in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Avalyn to Participate in Upcoming Investor Conference in April - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/","og_locale":"en_US","og_type":"article","og_title":"Avalyn to Participate in Upcoming Investor Conference in April","og_description":"CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) &#8212; Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inh","og_url":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-04-10T12:01:46+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/04\/Avalyn-Pharma-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Avalyn to Participate in Upcoming Investor Conference in April","datePublished":"2025-04-10T12:01:46+00:00","dateModified":"2025-04-10T12:01:46+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/"},"wordCount":283,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/","url":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/","name":"Avalyn to Participate in Upcoming Investor Conference in April - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-04-10T12:01:46+00:00","dateModified":"2025-04-10T12:01:46+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/avalyn-to-participate-in-upcoming-investor-conference-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Avalyn to Participate in Upcoming Investor Conference in April"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=66540"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/66540\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/66541"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=66540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=66540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=66540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}